population health header image

Population Health Publications

2026

Kessler ER, Min SJ, Hoover K, Coats H, Fischer SM. Feasibility and Acceptability of the ABC123 Framework for Advanced Cancer Care: Study Protocol. Nurs Res. 2026 Feb 3. doi: 10.1097/NNR.0000000000000888. Epub ahead of print. PMID: 41630360.

Miller CEF, Luehring JN, Kuna EBM, Bhatia S, Green AL, Compas BE. Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders. Pediatr Blood Cancer. 2026 Jan;73(1):e32131. doi: 10.1002/pbc.32131. Epub 2025 Oct 27. PMID: 41146465; PMCID: PMC12890220.

2025

Bradley CJ, Liang R, Lindrooth RC, Sabik LM, Perraillon MC. High-Cost Cancer Drug Use in Medicare Advantage and Traditional Medicare. JAMA Health Forum. 2025 Jan 3;6(1):e244868. doi: 10.1001/jamahealthforum.2024.4868. PMID: 39792400; PMCID: PMC11724345.

Callihan EB, Kuna EM, Eule CJ, Kessler ER, Flaig TW. Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer. Bladder Cancer. 2025 Jan 31;11(1):23523735241310388. doi: 10.1177/23523735241310388. PMID: 40034243; PMCID: PMC11868797.

Holmstoen TB, Volino LK, Molina Kuna E, Banerjee T, Fishbein L, Wierman ME, Kiseljak-Vassiliades K. Geographical Variation in Adrenocortical Carcinoma Incidence Across Colorado. J Endocr Soc. 2025 Apr 8;9(5):bvaf057. doi: 10.1210/jendso/bvaf057. PMID: 40206460; PMCID: PMC11979453.

Jazowski SA, Achola EM, Nicholas LH, Wood WA, Friese CR, Dusetzina SB. Estimating financial and health burden by initial Medicare plan choice and history of cancer. Health Aff Sch. 2025 Jan 21;3(1):qxaf001. doi: 10.1093/haschl/qxaf001. PMID: 39839086; PMCID: PMC11747364.

Perraillon MC, Warren A, Goldman L, Studts JL, Myerson RM. Delaying Screening Until Covered? Changes in Lung Cancer Screening at the Age of Nearly-Universal Medicare Insurance. Health Serv Res. 2025 May 8:e14638. doi: 10.1111/1475-6773.14638. Epub ahead of print. PMID: 40344226.

Zhao J, Perraillon M, Clark RM, Greenwald SJ, Pollyea DA, Han X, Yabroff KR, Bradley CJ, Parsons HM. County-level medical debt and treatment initiation among individuals newly diagnosed with cancer. Cancer. 2025 Nov 1;131(21):e70133. doi: 10.1002/cncr.70133. PMID: 41139228.

2024

Collins A, Molina Kuna E, Anderson-Mellies A, Cost C, Green AL. Investigating the Impact of Tumor Biology and Social Determinants on Time to Diagnosis and Stage at Presentation of Wilms Tumor. J Pediatr Hematol Oncol. 2024 Apr 1;46(3):147-153. doi: 10.1097/MPH.0000000000002846. Epub 2024 Mar 4. PMID: 38447110; PMCID: PMC10956656.

Eule CJ, Kuna EM, Robin TP, Gershman B, Flaig TW, Kim SP. Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database. Urol Oncol. 2024 Dec;42(12):447.e17-447.e24. doi: 10.1016/j.urolonc.2024.07.002. Epub 2024 Aug 26. PMID: 39191549; PMCID: PMC11573622.

Eule CJ, Warren A, Molina Kuna E, Callihan EB, Kim SP, Flaig TW. Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen. Urology. 2024 Jun;188:118-124. doi: 10.1016/j.urology.2024.04.034. Epub 2024 Apr 28. PMID: 38685388.

Eule CJ, Warren A, Molina Kuna E, Robin TP, Gershman B, Kim SP, Flaig TW. Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database. Prostate Cancer Prostatic Dis. 2024 Nov 21. doi: 10.1038/s41391-024-00914-z. Epub ahead of print. PMID: 39572637.

Hannemann A, Pessoa RR, Flaig T, Kuna EM, Warren A, Robin T, Kim SP, Ballon-Landa E. Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims database. Urol Oncol. 2024 Aug;42(8):246.e1-246.e5. doi: 10.1016/j.urolonc.2024.03.008. Epub 2024 Apr 27. PMID: 38679529.

Nicholas LH, Fischer SM, Arbaje AI, Perraillon MC, Jones CD, Polsky D. Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare. JAMA Health Forum. 2024 Jul 5;5(7):e241777. doi: 10.1001/jamahealthforum.2024.1777. PMID: 39028655; PMCID: PMC11259900.

Roy S, Lakritz S, Schreiber AR, Kuna EM, Bradley CJ, Kondapalli L, Diamond JR. Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study. Eur J Cancer. 2024 Jan;196:113426. doi: 10.1016/j.ejca.2023.113426. Epub 2023 Nov 11. PMID: 38000217.

Wiesen BM, Flaig TW, Gershman B, Konety B, Warren A, Kuna EM, Robin T, Kessler ER, Eule CJ, Breyer BN, Achua J, Kim SP. Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices. Adv Urol. 2024 Dec 19;2024:8871425. doi: 10.1155/aiu/8871425. PMID: 39735345; PMCID: PMC11671626.

 

2023

Bradley, Cathy J. PhD; Liang, Rifei MA; Lindrooth, Richard C. PhD; Sabik, Lindsay M. PhD; Perraillon, Marcelo C. PhD. Building Data Infrastructure for Disease-Focused Health Economics Research. Medical Care 61(12):p S147-S152, December 2023. | DOI: 10.1097/MLR.0000000000001904

Bradley CJ, Sabik LM, Liang R, Lindrooth RC, Perraillon MC. Treatment Disparities in Radiation and Hormone Therapy Among Women Covered by Medicaid vs Private Insurance in Cancer Registry and Claims Data. JAMA Health Forum. 2023;4(5):e230673. doi:10.1001/jamahealthforum.2023.0673

Callaway C, Kuna EM, Overholser L. Development of a novel cancer survivorship database to describe health care utilization patterns for Coloradans who have completed primary cancer treatment. J Cancer Surviv. 2023 Dec 23. doi: 10.1007/s11764-023-01506-x. Epub ahead of print. PMID: 38135830.

Candelario NC, Molina E, Bourlon MT, Kim SP, Kessler ER, Spiess PE, Flaig TW. Racial differences in survival for early stage (T1) penile cancer: Analysis from the SEER database. Urol Oncol. 2023 Jun 19:S1078-1439(23)00193-X. doi: 10.1016/j.urolonc.2023.05.018. Epub ahead of print. PMID: 37344326.

McDermott JD, Amini A, Molina E, Stokes WA, Karam SD. Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer. Head Neck. 2023 Mar;45(3):664-674. doi: 10.1002/hed.27284. Epub 2022 Dec 23. PMID: 36563300; PMCID: PMC10626713.

Hamer MK, DeCamp M, Bradley CJ, Nease DE Jr, Perraillon MC. Adoption and Value of the Medicare Annual Wellness Visit: A Mixed-Methods Study. Med Care Res Rev. 2023 Aug;80(4):433-443. doi: 10.1177/10775587231166037. Epub 2023 Apr 26. PMID: 37098854.

Kiani K, Kim SP, Pessoa RR, Gershman B, Gonzalez C, Molina E, Warren A, DaSilva RD, Chapin B, Ballon-Landa E. Association of Frailty and Complications Following Prostate Biopsy: Results From a Population-Based, Privately Insured Cohort. Urol Pract. 2024 Jan;11(1):117-122. doi: 10.1097/UPJ.0000000000000476. Epub 2023 Nov 1. PMID: 37914379.

Lind KT, Molina E, Mellies A, Schneider KW, Daley W, Green AL. Early death from childhood cancer: First medical record-level analysis reveals insights on diagnostic timing and cause of death. Cancer Med. 2023 Oct;12(19):20201-20211. doi: 10.1002/cam4.6609. Epub 2023 Oct 3. PMID: 37787020; PMCID: PMC10587965.

Roy S, Lakritz S, Schreiber AR, Molina E, Kabos P, Wood M, Elias A, Kondapalli L, Bradley CJ, Diamond JR. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study. Eur J Cancer. 2023 May;185:69-82. doi: 10.1016/j.ejca.2023.02.014. Epub 2023 Feb 28. PMID: 36965330.

2022

Barnard JG, Marsh R, Anderson-Mellies A, Williams JL, Fisher MP, Cockburn MG (CPC), Dempsey AF (CPC), Cataldi JR (CPC). Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics. Vaccine. 2022 Aug 5;40(33):4835-4844. doi: 10.1016/j.vaccine.2022.06.074. Epub 2022 Jul 2. PMID: 35792022.

Bradley CJ (CPC), Anderson-Mellies A, Borrayo EA (CPC-COE), Doherty JA, Escontrías OA, Garcia DO, Mishra SI, Sussman AL, Thomson CA, Wetter DW, Cook LS (CPC). Ethnicity, socioeconomic status, income inequality, and colorectal cancer outcomes: evidence from the 4C2 collaboration. Cancer Causes Control. 2022 Apr;33(4):533-546. doi: 10.1007/s10552-021-01547-6. Epub 2022 Jan 4. PMID: 34982317.

Bradley CJ (CPC), Entwistle J, Sabik LM, Lindrooth RC, Perraillon M (CPC). Capitalizing on Central Registries for Expanded Cancer Surveillance and Research. Med Care. 2022 Feb 1;60(2):187-191. doi: 10.1097/MLR.0000000000001675. PMID: 35030567; PMCID: PMC8820319.

Bradley CJ (CPC), Liang R, Jasem J, Lindrooth RC, Sabik LM, Perraillon MC (CPC). Cancer Treatment Data in Central Cancer Registries: When Are Supplemental Data Needed? Cancer Inform. 2022 Jul 30;21:11769351221112457. doi: 10.1177/11769351221112457. PMID: 35923286; PMCID: PMC9340909.

Bourlon MT, Verduzco-Aguirre H, Molina E, Meyer E, Kessler E, Kim SP (CPC), Spiess PE, Flaig T (DT). Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis. Front Oncol. 2022 Jun 29;12:926692. doi: 10.3389/fonc.2022.926692. PMID: 35847850; PMCID: PMC9277543.

Hart M, Anderson-Mellies A, Beltrami A, Gilani A, Green AL (MCO). Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups. J Neurooncol. 2022 Apr;157(2):333-344. doi: 10.1007/s11060-022-03967-z. Epub 2022 Feb 17. PMID: 35175546.

Sun J, Perraillon MC (CPC), Myerson R. The Impact of Medicare Health Insurance Coverage on Lung Cancer Screening. Med Care. 2022 Jan 1;60(1):29-36. doi: 10.1097/MLR.0000000000001655. PMID: 34739415; PMCID: PMC8663516.

Schreiber AR, Kagihara J, Eguchi M, Kabos P (THI), Fisher CM (CPC), Meyer E, Molina E, Kondapalli L, Bradley CJ (CPC), Diamond JR (DT). Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast Cancer Res Treat. 2022 Jan;191(2):389-399. doi: 10.1007/s10549-021-06424-z. Epub 2021 Oct 27. PMID: 34705147; PMCID: PMC8763743.

Singh S, Molina E, Meyer E, Min SJ, Fischer S (CPC). Post-Acute Care Outcomes and Functional Status Changes of Adults with New Cancer Discharged to Skilled Nursing Facilities. J Am Med Dir Assoc. 2022 Mar 23:S1525-8610(22)00192-X. doi: 10.1016/j.jamda.2022.02.010. Epub ahead of print. PMID: 35337793.

Sterbis E, Liang R, Trivedi P, Kwak J, Cohen Major E, Karam SD (DT), Morgan R# (CPC). Lack of adherence to guideline-based imaging prior to subsequent radiation in patients with non-small cell lung cancer: Impact on patient outcomes. J Nucl Med. 2022 Jun 9:jnumed.122.264131. doi: 10.2967/jnumed.122.264131. Epub ahead of print. PMID: 35680415.

2021

Huynh V, Colborn K, Smith S, Bonnell LN, Ahrendt G, Christian N, Kim S, Matlock DD, Lee C, Tevis SE. Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2021 Oct;28(10):5677-5685. doi: 10.1245/s10434-021-10450-y. Epub 2021 Jul 15. PMID: 34263375.

Morgan RL# (CPC), Eguchi M, McDermott J (DT), Mueller AC, Amini A, Goddard JA, Trivedi PS, Karam SD (DT). Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer. Cancer. 2021 Feb 15;127(4):535-543. doi: 10.1002/cncr.33244. Epub 2020 Oct 29. PMID: 33119176.

Perraillon MC (CPC), Liang R, Sabik LM, Lindrooth RC, Bradley CJ (CPC). The role of all-payer claims databases to expand central cancer registries: Experience from Colorado. Health Serv Res. 2022 Jun;57(3):703-711. doi: 10.1111/1475-6773.13901. Epub 2021 Nov 15. PMID: 34743320; PMCID: PMC9108037.

Sakamoto MR, Eguchi M, Azelby CM, Diamond JR (DT), Fisher CM, Borges VF (THI), Bradley CJ (CPC), Kabos P (THI). New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer. J Natl Compr Canc Netw. 2021 Jan 6;19(1):29-38. doi: 10.6004/jnccn.2020.7612. PMID: 33406490.

Stokes WA (DT-UCD), Molina E, McDermott JD (DT), Morgan RL# (CPC), Bickett T, Fakhoury KR, Amini A, Karam SD (DT). Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer. Head Neck. 2021 Nov;43(11):3255-3275. doi: 10.1002/hed.26809. Epub 2021 Jul 21. PMID: 34289190; PMCID: PMC8511271.

CMS Login